FinTrust Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.17M | Sell |
1,950
-34
| -2% | -$37.8K | 0.37% | 57 |
|
|
2024
Q2 | $2.09M | Sell |
1,984
-39
| -2% | -$41K | 0.38% | 55 |
|
|
2024
Q1 | $1.95M | Sell |
2,023
-63
| -3% | -$60.6K | 0.38% | 55 |
|
|
2023
Q4 | $1.83M | Buy |
2,086
+149
| +8% | +$131K | 0.37% | 55 |
|
|
2023
Q3 | $1.59M | Sell |
1,937
-82
| -4% | -$67.5K | 0.35% | 58 |
|
|
2023
Q2 | $1.45M | Buy |
2,019
+250
| +14% | +$180K | 0.35% | 72 |
|
|
2023
Q1 | $1.33M | Hold |
1,769
| – | – | 0.32% | 75 |
|
|
2022
Q4 | $1.28M | Sell |
1,769
-72
| -4% | -$52K | 0.31% | 78 |
|
|
2022
Q3 | $1.31M | Buy |
1,841
+48
| +3% | +$34.2K | 0.34% | 72 |
|
|
2022
Q2 | $1.05M | Sell |
1,793
-218
| -11% | -$128K | 0.26% | 89 |
|
|
2022
Q1 | $1.41M | Buy |
2,011
+1,393
| +225% | +$973K | 0.32% | 71 |
|
|
2021
Q4 | $389K | Sell |
618
-481
| -44% | -$303K | 0.09% | 192 |
|
|
2021
Q3 | $665K | Buy |
1,099
+824
| +300% | +$499K | 0.18% | 115 |
|
|
2021
Q2 | $154K | Buy |
275
+38
| +16% | +$21.3K | 0.04% | 326 |
|
|
2021
Q1 | $112K | Buy |
237
+162
| +216% | +$76.6K | 0.03% | 385 |
|
|
2020
Q4 | $36K | Buy |
+75
| New | +$36K | 0.01% | 541 |
|
|
2019
Q2 | – | Sell |
-32
| Closed | -$13K | – | 1214 |
|
|
2019
Q1 | $13K | Hold |
32
| – | – | 0.01% | 706 |
|
|
2018
Q4 | $12K | Buy |
+32
| New | +$12K | 0.01% | 720 |
|